CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Kexin Biotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Kexin Biotech Co Ltd
Room 501, 5F, No 9 Building
No.1011 Halei Rd, Zhangjiang Hi Tech Prk
Phone: +86 2151320126p:+86 2151320126 SHANGHAI, SHA  201203  China Fax: +86 2151320107f:+86 2151320107
Business Summary
Shanghai Kexin Biotech Co., Ltd. is a China-based company principally engaged in the development, production and sale of new diagnostic reagents and biological drugs. The Company mainly provides self-manufactured products, purchased products, technical services and others. Its self-manufactured products include immune disease diagnostic reagents, immune detection kits used for diagnosis of primary biliary cirrhosis (PBC) and rheumatoid arthritis, as well as anti-double stranded deoxyribonucleic acid (dsDNA) used for diagnosis of systemic lupus erythematosus, among others. Its purchased products include anticardiolipin, as well as antinuclear and antibody detection kits, among others.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201312/31/2012Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries
8999 Services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager JunBao

General Information
Fax Number: +86 2151320107


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023